GlassScriptPhysician profile
Patrick Houlihan
NPI 1366128258
$364.48
in general payments reported to CMS, 2019-2025
12 companies · $192 in 2025
The $192 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $172 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $364.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $61.86 | 2024-2025 | |
| Dexcom, INC. | $51.75 | 2025 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $37.43 | 2025 | Ozempic |
| Lilly USA, LLC | $30.30 | 2024 | Mounjaro, Zepbound |
| Janssen Pharmaceuticals, INC | $29.80 | 2024 | Xarelto |
| Otsuka America Pharmaceutical, INC. | $28.46 | 2024 | Jynarque |
| Aurinia Pharma U.S., INC. | $26.00 | 2024 | Lupkynis |
| Averitas Pharma INC. | $25.58 | 2025 | Qutenza |
| Novartis Pharmaceuticals Corporation | $20.97 | 2024 | |
| Janssen Biotech, INC. | $20.83 | 2025 | Tremfya |
| Travere Therapeutics, INC. | $16.88 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.62 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Houlihan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.